株式会社極東書店トップ ＞ 商品一覧 ＞ Design of Caspase Inhibitors as Potential Clinical Agents.
商品詳細
Design of Caspase Inhibitors as Potential Clinical Agents.
・ISBN 978-1-4200-4540-6 hard GB£ 260.00
￥82,368.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | O'Brien, Tom / Linton, Steven D. (eds.), |
|---|---|
| 出版社 | (CRC Press Inc, US) |
| 出版年月 | 2008 |
| ページ数 | 312 pp. |
| 言語 | ENG |
| ニュース番号 | ＜A00-50960＞ |
解説
Presents the Therapeutic Potential for Caspase Inhibitors: Present and Future
Caspases represent one of the most specific protease families described to date. These extremely important enzymes are crucial to the destruction of aberrant cells - the body's self-protection mechanism for warding off the growth of abnormal cells, many of which can promote cancer. Design of Caspase Inhibitors as Potential Clinical Agents introduces cutting-edge evidence regarding caspases' role in pro-inflammatory responses. New research now shows that the inhibition of caspase function is a critical component for the treatment of many diseases, including:
- Arthritic and neurological disorders
- Lung disease
- Hereditary fever syndromes
- Inflammatory bowel and skin diseases
- Sepsis
- Liver fibrosis
Outlines Efforts to Develop Molecule Inhibitors for Caspase Activity Transformation
Under the editorial guidance of authoritative inflammatory disease, small molecule discovery, and apoptosis researchers, the book organizes the wide array of caspase literature into one convenient resource. It also summarizes the relative difficulty of transitioning a caspase small molecule inhibitor from the lab to the clinic and suggests approaches to circumvent this difficulty. Taking a novel, yet core approach to disease treatment, this seminal work sets the stage to combat a slew of debilitating diseases through groundbreaking drug development.